InvestorsHub Logo
Followers 8
Posts 549
Boards Moderated 0
Alias Born 02/03/2017

Re: searching4rainbow post# 20682

Thursday, 03/08/2018 3:01:31 PM

Thursday, March 08, 2018 3:01:31 PM

Post# of 233151
Also, to add to what Gestalt has said, Misiu has also addressed this multiple times on this board....as those of us in the medical field know, the Thaimed drug can only be given intravenously (IV) by a nurse either in a hospital, clinic, or at home by a home-health RN. This is not an easy administration for the patient, and can only be tolerated for so long before it becomes quite prohibitive, especially if the patient has poor IV access (bad veins). Also, with the low (~40%) viral suppression rate and high level of unpleasant side effects I can’t imagine people flocking to this unless it’s a last resort.
On the contrary, Pro 140 can be easily administered by the patient at home subcutaneously (SC) once per week, with proven tremendous viral load suppression and minimal to no side effects noted in the trials so far.
These differences illustrate the tremendous advantages Pro 140 presents potentially to patients and is why (I think) many of us are quite confident in this getting to market.
Long response but hopefully answers some of your questions.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News